Release Date: 06/09/22 13:56 Summary: Units on Issue Disclosure - August 2022 Price Sensitive: No Download Document 116.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%